Stock Scorecard

Stock Summary for Alzamend Neuro Inc (ALZN) - $0.75 as of 4/18/2024 8:47:29 AM EST

Total Score

7 out of 29

Currently on the following lists
None
Tim's Recommendation
Avoid

Growth List Algorithm Criteria for ALZN

Positive earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for ALZN

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for ALZN

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2

Bonus Criteria for ALZN

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Latest News for for ALZN

Aldeyra Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying - Aldeyra Therapeutics ( NASDAQ:ALDX ) , Alzamend Neuro ( NASDAQ:ALZN ) 4/4/2024 10:23:00 AM
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying - Alzamend Neuro ( NASDAQ:ALZN ) , Anitra ( AMEX:AZTR ) 4/2/2024 11:39:00 AM
Alzamend Neuro And 3 Other Stocks Under $3 Insiders Are Buying - Alzamend Neuro ( NASDAQ:ALZN ) , Fortress Biotech ( NASDAQ:FBIO ) 1/10/2024 1:09:00 PM
EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year - Alzamend Neuro ( NASDAQ:ALZN ) 12/11/2023 12:30:00 PM
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket - Acutus Medical ( NASDAQ:AFIB ) , AgileThought ( NASDAQ:AGIL ) 11/21/2023 1:05:00 PM
EXCLUSIVE: Alzamend Neuro Receives FDA Go-Ahead Letter For Mid-Stage Major Depressive Disorder Study - Alzamend Neuro ( NASDAQ:ALZN ) 11/20/2023 12:30:00 PM
EXCLUSIVE: Alzamend Neuro Seeks FDA Approval For Mid-Stage PTSD Study With Next‑Gen Lithium Therapeutic Drug Candidate - Alzamend Neuro ( NASDAQ:ALZN ) 11/13/2023 12:34:00 PM
Dow Surges Over 500 Points; Western Digital Announces Plan To Split Into Two Companies - Alzamend Neuro ( NASDAQ:ALZN ) , CommScope Hldg Co ( NASDAQ:COMM ) 10/30/2023 7:06:00 PM
Crude Oil Falls Over 3%; Miromatrix Medical Shares Spike Higher - Alzamend Neuro ( NASDAQ:ALZN ) , CommScope Hldg Co ( NASDAQ:COMM ) 10/30/2023 4:14:00 PM
Why Alzamend Neuro ( ALZN ) Stock Is Nosediving Today - Alzamend Neuro ( NASDAQ:ALZN ) 10/30/2023 2:16:00 PM

Financial Details for ALZN

Company Overview
Ticker ALZN
Company Name Alzamend Neuro Inc
Country USA
Description N/A
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 1/31/2024
Next Earnings Date N/A

Stock Price History
Last Day Price 0.75
Last Day Price Updated 4/18/2024 8:47:29 AM EST
Last Day Volume 58,033
Average Daily Volume 66,976
52-Week High 11.91
52-Week Low 0.74
Last Price to 52 Week Low 1.35%

Valuation Measures
Trailing PE N/A
Industry PE 102.57
Sector PE 61.99
5-Year Average PE -55.01
Free Cash Flow Ratio 18.75
Industry Free Cash Flow Ratio 12.74
Sector Free Cash Flow Ratio 30.47
Current Ratio Most Recent Quarter 0.16
Total Cash Per Share 0.04
Book Value Per Share Most Recent Quarter -0.63
Price to Book Ratio 7.23
Industry Price to Book Ratio 5.66
Sector Price to Book Ratio 22.08
Price to Sales Ratio Twelve Trailing Months 0.00
Industry Price to Sales Ratio Twelve Trailing Months 5.48
Sector Price to Sales Ratio Twelve Trailing Months 5.19

Share Statistics
Total Shares Outstanding 6,866,800
Market Capitalization 5,150,100
Institutional Ownership N/A

Dividends
Ex-Dividend Date N/A
Last Dividend Amount 0.00
Current Dividend Amount 0.00
Dividend Aristocrat? False
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement
Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth -20.35%
Reported EPS 12 Trailing Months -1.82
Reported EPS Past Year -0.86
Reported EPS Prior Year -0.15
Net Income Twelve Trailing Months -12,401,745
Net Income Past Year -14,878,167
Net Income Prior Year -12,362,059
Quarterly Revenue Growth YOY 0.00%
5-Year Revenue Growth 0.00%

Balance Sheet
Total Cash Most Recent Quarter 282,867
Total Cash Past Year 5,140,859
Total Cash Prior Year 14,063,811
Net Cash Position Most Recent Quarter -62,026
Net Cash Position Past Year 4,805,556
Long Term Debt Past Year 335,303
Long Term Debt Prior Year 335,303
Total Debt Most Recent Quarter 344,893
Equity to Debt Ratio Past Year 0.90
Equity to Debt Ratio Most Recent Quarter 0.00
Total Stockholder Equity Past Year 3,045,503
Total Stockholder Equity Prior Year 13,351,511
Total Stockholder Equity Most Recent Quarter -4,263,821

Options
Put/Call Ratio 0.00
Has Options Options Chain
Liquidity Rating

Technical Analysis
Yahoo Finance Chart Yahoo Finance Chart
MACD -0.03
MACD Signal -0.02
20-Day Bollinger Lower Band 0.74
20-Day Bollinger Middle Band 0.93
20-Day Bollinger Upper Band 1.12
Beta 0.02
RSI 40.70
50-Day SMA 3.70
200-Day SMA 0.00

System
Modified 4/17/2024 5:22:03 PM EST